Zheng, J., Yu, J., Yang, M., & Tang, L. (2019). Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition. Exp Ther Med.
Chicago-stil citatZheng, Jianyun, Jianxin Yu, Min Yang, och Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
MLA-referensZheng, Jianyun, Jianxin Yu, Min Yang, och Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.